Format

Send to

Choose Destination
See comment in PubMed Commons below
Psychopharmacology (Berl). 2008 Mar;196(4):511-20; discussion 521-2. Epub 2007 Oct 23.

Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.

Author information

1
University of Ulm, Ulm, Germany. stefan.weinmann@gmx.de

Abstract

RATIONALE:

A number of reviews have claimed that the selective serotonin and noradrenalin re-uptake inhibitor venlafaxine is more effective than selective serotonin re-uptake inhibitors (SSRIs) in achieving remission and symptom reduction in major depression.

OBJECTIVES:

The aim of this study was to systematically review studies on the efficacy of venlafaxine vs SSRI and to evaluate the influence of methodological issues on the effect sizes.

MATERIALS AND METHODS:

Following a systematic literature search, we pooled data on depression scores, response, remission and dropout rates. We also performed sub-group analyses.

RESULTS:

Seventeen studies were included. We found no significant superiority in remission rates (risk ratio [RR] = 1.07, 95% confidence intervals [95%CI] = 0.99 to 1.15, numbers needed to treat [NNT] = 34) and a small superiority in response rates (RR = 1.06, 95%CI = 1.01 to 1.12, NNT = 27) over SSRIs. There was a small advantage to venlafaxine in change scores (effect size = -0.09, 95%CI = -0.16 to -0.02, p = 0.013), which did not reach significance when post-treatment scores were used (effect size = -0.06, 95%CI = -0.13 to 0.00). Discontinuation rates due to adverse events were 45% higher in the venlafaxine group. The main reasons for the differences between this analysis and previous reviews were the exclusion of studies with methodological limitations, avoiding to pool selectively reported study results and exclusion of studies available as abstracts only.

CONCLUSIONS:

Our analysis does not support a clinically significant superiority of venlafaxine over SSRIs. Differences between our study and previous reviews were not accounted for by technical aspects of data synthesis, but rather by study selection and choice of outcome parameters.

Comment in

PMID:
17955213
DOI:
10.1007/s00213-007-0975-9
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Health
    Loading ...
    Support Center